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SUMMARY
An international consensus clinical practice statement issued in 2011 ranked psy-
chogenic nonepileptic seizures (PNES) among the top three neuropsychiatric prob-
lems. An ILAE PNES Task Force was founded and initially charged with summarizing
the current state of the art in terms of diagnosis and treatment, resulting in two publi-
cations. The first described different levels of diagnostic certainty. The second summa-
rized current knowledge of management approaches. The present paper summarizes
an international workshop of the ILAE PNES Task Force that focused on the current
understanding and management of PNES around the world. We initially provide a
knowledge update about the etiology, epidemiology, and prognosis of PNES—in adults
and in special patient groups, such as children, older adults, and those with intellectual
disability. We then explore clinical management pathways and obstacles to optimal
care for this disorder around the world by focusing on a number of countries with dif-
ferent cultural backgrounds and at very different stages of social and economic devel-
opment (United Kingdom, U.S.A., Zambia, Georgia, China, and Japan). Although
evidence-based methods for the diagnosis and treatment of PNES have now been
described, and much is known about the biopsychosocial underpinnings of this disor-
der, this paper describes gaps in care (not only in less developed countries) that result
in patients with PNES not having adequate access to healthcare provisions. A range of
challenges requiring solutions tailored to different healthcare systems emerges. Con-
tinued attention to PNES by the ILAE and other national and international neurologic,
psychiatric, and health organizations, along with ongoing international collaboration,
should ensure that patients with PNES do not lose out as healthcare services evolve
around theworld.
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In 2011, a consensus clinical practice statement based on
an international survey of experts carried out by the Com-
mission on Neuropsychiatric Aspects of Epilepsy of the
International League Against Epilepsy (ILAE) ranked psy-
chogenic nonepileptic seizures (PNES) among the top three
neuropsychiatric problems with anxiety/depression and psy-
chotic disorder.1 PNES are clinically defined as events
resembling epileptic seizures but caused by psychological
processes. Most are classified in the Diagnostic and Statisti-
cal Manual of Mental Disorders (DSM-5) as a conversion
disorder.2 On the basis of results of the survey mentioned
above, an ILAE PNES task force was founded and initially
charged with summarizing the state of the art in terms of
diagnosis and treatment. Two consensus publications
resulted from this assignment. One established different
levels of diagnostic certainty, depending on the data avail-
able to clinicians at the point of diagnosis.3 The other sum-
marized management approaches described in the
literature.4 Having completed these projects, the ILAE task
force turned its attention to the topic of PNES around the
world. Prior studies have described treatment practices for
PNES in the U.S.A., United Kingdom, Chile, and Brazil.5–8
The present paper summarizes presentations at a joint meet-
ing of the ILAE PNES Task Force and the Japan Epilepsy
Society in Nagasaki, Japan, in October 2015. After provid-
ing a brief knowledge update about PNES, we discuss some
particular patient subgroups before exploring the challenges
associated with the provision of care around the world for
patients with PNES by focusing on six countries that repre-
sent different cultures and stages of socioeconomic develop-
ment. Finally, we consider approaches that may help close
gaps in diagnostic and treatment services for PNES in dif-
ferent countries.
Knowledge Update
In the absence of well-resourced, formal epidemiological
studies, the prevalence of PNES is very difficult to deter-
mine. Long delays from seizure onset to accurate diagnosis
and a tendency for patients with PNES to disengage from
medical services after diagnosis mean that a substantial sub-
population of patients with PNES disorders will not be easy
to identify, even in developed countries. Epidemiological
data from poorer countries are virtually lacking altogether.
One estimate based on the number of patients referred to
epilepsy centers who are thought to have severe epilepsy
but who turn out to have PNES yielded a possible preva-
lence range of 2–33/100,000 (0.002–0.033%).9 Alterna-
tively, one could generate an estimate based on the
assumption of a similar long-term course as for epilepsy and
an extrapolation from incidence figures. Following this
approach, an incidence figure of 5/100,000/year would yield
an estimated prevalence of approximately 1/10 that of epi-
lepsy, or 5/100,000.
The incidence of PNES is somewhat easier to study and
has recently been determined to be 4.09/100,000 in a study
based in the United Kingdom.10 To date, comparative dif-
ferences in the incidence and prevalence of PNES around
the world have not been studied. However, research from
many countries documents that PNES is not a disorder that
only exists in the developed world. In addition to presenta-
tions closely resembling those in Western and other highly
industrialized societies, PNES-like states are also recog-
nized in some cultures around the world as a cultural phe-
nomenon.11
A “gold standard” diagnosis of PNES is based on a his-
tory consistent with PNES and the recording of a typical
event with semiological features of PNES but no epilepti-
form activity in the electroencephalogram (EEG) before,
during, or after the ictus. The combination of a history,
semiology, and video EEG findings consistent with PNES
provides the level “documented” PNES. However, the
recognition of PNES diagnoses with lower levels of cer-
tainty is important, because not all sites (or patients) around
the world have access to video EEG and clinicians and
patients may have to make treatment choices (for instance,
about stopping inappropriate antiepileptic drugs or com-
mencing psychological treatment) when the diagnosis is not
completely certain. These levels include in descending
order “clinically established,” “probable,” and “possible.”3
Our understanding of the etiology of PNES has improved
significantly over the last two decades.12 PNES are a multi-
factorial biopsychosocial disorder. No single mechanism or
contributing factor has been identified as necessary and suf-
ficient to explain the disorder in all cases.13,14 Traditionally
conversion disorder, dissociative mechanisms, and stress-
related factors have been considered in psychopathological
models of PNES.12,15 However, more comprehensive, inte-
grative models of PNES have been developed that take into
account a wider range of possible pathopsychological mech-
anisms, including abnormal arousal and inhibition (see
Fig. 1).16,17 Although patients do not universally report
trauma or neglect in early life, studies using different self-
report and experimental methodologies have identified
adverse childhood experiences as a factor predisposing to
the development of PNES in later life.18,19 Many (but not
Key Points
• This paper summarizes the discussions focusing on
the current understanding and management of PNES
around the world
• We initially provide a knowledge update about the eti-
ology, epidemiology, and subgroup of PNES
• We then demonstrate clinical management and obsta-
cles for this disorder in six countries (United King-
dom, U.S.A., Zambia, Georgia, China, and Japan)
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all) patients with PNES also report trauma in adult life,
potentially leaving them with symptoms of posttraumatic
stress disorder (PTSD), such as hypo- or hyperarousal and
flashbacks.20 To date, no research has explored differences
in the psychiatric comorbidity or the psychopathological
underpinnings of PNES comparing different cultures or
countries around the world, although studies have reported
differing rates of previous sexual abuse in women with
PNES in Eastern andWestern countries.20–23
The burden associated with PNES is considerable for
healthcare systems and societies at large, as well as for
affected individuals and their families.24 It is estimated that
20–30% of patients referred to epilepsy centers with intract-
able seizures have been misdiagnosed with epilepsy—the
vast majority of these patients are eventually diagnosed with
PNES.25 In addition to the direct healthcare costs associated
with PNES, indirect costs to patients and caregivers caused
by loss of employment and reduced availability for house-
hold work have great societal impact.26 Several studies have
found that direct healthcare costs decline following the
diagnosis of PNES because of substantial reductions in
healthcare resource utilization.27,28 The early reduction in
healthcare use is often sustained over the longer term,
although long-term employment outcomes do not seem
favorable.29,30 Randomized clinical trials (RCTs) now pro-
vide an evidence base for different psychological treatment
approaches for PNES (although it is not certain to what
extent the findings of these studies can be generalized to
poorer countries).31 Although the health economic effects
of psychological treatments have not been studied in ran-
domized trials, observational studies suggest that psycho-
logical interventions can reduce healthcare costs associated
with PNES.32
PNES in Different
Subpopulations
PNES is well documented in children;33,34 however, there
is a lack of population-based data on the prevalence or inci-
dence of PNES in the pediatric population. Studies reveal
better outcomes for children than for adults with PNES.35
Studies of children up to 12 years of age have identified the
following patient characteristics: PNES have been reported
from the age of 3 years;32 unlike in adults, there is no
female predominance; motor inhibition (dialeptic attacks)
was more common than hyper-motor-type events;34,36 a his-
tory of physical or sexual abuse is reported less commonly
by pediatric than by adult patients.33 School phobia or diffi-
culties in school (including bullying, specific learning diffi-
culties, or unrealistic expectations) have been reported as
the most common precipitating or perpetuating factors.33 A
number of neurologic, psychiatric, and psychosocial risk
factors have been reported for children and adolescents with
PNES.37,38
Figure 1.
Biopsychosical aspects of conversion disorder/functional neurological disorders (including psychogenic nonepileptic seizures). From
Voon V, et al. Functional neuroanatomy and neurophysiology of functional neurological disorders (conversion disorder). J Neuropsychia-
try Clin Neurosci 2016; 28(3):168–190.With permission fromCopyright©2016 American Psychiatric Association. All rights reserved.
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PNES are usually thought of as a disorder of younger
adults. They are likely to be underrecognized in older adults.
A number of studies have identified older patients who have
had PNES long term39–41 and patients whose PNES have
started in later life.42 One study showed that in patients with
a PNES onset in later life, seizures often seemed to be pre-
cipitated by health-related traumatic experiences.43 In the
same study, patients with late-onset PNES had better base-
line psychological health and reported a lower rate of sexual
abuse than younger adults with PNES. Unlike in younger
adults (but similar to in children), the gender ratio was even.
There may be a tendency for older adults to have PNES with
convulsive movements in the form of low-amplitude, high-
frequency tremors with partially preserved responsive-
ness.41,42 Physiological nonepileptic events such as postural
and cardiac syncope occur more commonly in elderly
patients41 and need to be considered carefully in the differ-
ential diagnosis of seizures.43
Patients with intellectual disability (ID) make up another
important PNES subgroup, and studies reveal that the pro-
portion of patients with PNES and comorbid ID is similar to
that of patients with PNES and additional epilepsy (i.e.,
about 10%).44,45 One study focusing on patients with PNES
and ID suggested that this particular subgroup of patients
differed from those with PNES but no ID in a number of
ways. In the group with ID, there was a trend toward a male
preponderance, relative paucity of antecedent sexual abuse,
frequent episodes of psychogenic nonepileptic status, as
well as a greater proportion of patients in whom situational
or emotional triggers immediately preceding individual
PNES were reported.46 Gates and Erdahl47proposed “a rein-
forced behavior pattern” as a particularly important patho-
genetic factor leading to PNES in patients with comorbid
ID,47 an idea reemphasized in the study by Magaudda
et al.48 In view of the somewhat different etiology of PNES
in this patient subgroup, treatment may need to be different
as well. A therapeutic approach combining the modification
of the patient’s environment and mind-set may be particu-
larly useful.49
Unfortunately, no data are available about PNES in these
specific subgroups from less highly developed regions of
the world. However, awareness of these patient subgroups
needs to be promoted around the world to ensure that
PNES are not overlooked or mistreated in these subpopula-
tions.
PNES around the World
This section describes services for PNES in six coun-
tries with different sociocultural backgrounds and at dif-
ferent stages of economic development. These examples
provide an impression of the range of difficulties patients
with PNES are likely to encounter when they try to access
diagnostic or treatment services (see Table 1 for an over-
view).
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Zambia
Background
Epilepsy is the most common neurological condition,
affecting 14.5/1,000 of the population.50 Epilepsy is not
considered a “normal medical condition” by the population
but a mental disorder or form of “insanity.” The situation is
not better for patients with PNES.
Services
Most regional health care is provided by clinical officers
in psychiatry or general medicine with limited training.
These are not trained physicians. Expert care is centralized
in the capital, Lusaka. This makes it very difficult for
patients to access diagnostic facilities or benefit from the
advice of medical specialists.
Diagnosis
Regional health centers have no access to EEG, video-
EEG monitoring, 24-h EEG, or high-quality MRI/CT.
PNES diagnoses are mainly made by psychiatrists, neurolo-
gists (only present in very small numbers and usually found
centrally in tertiary hospitals), or clinical officers in psychi-
atry and general medicine.
Treatment
An estimated 80% of people with epilepsy receive treat-
ment from traditional healers who do not refer the patients
to health professionals even if they fail to improve with their
treatment.50,51 It is unknown how many patients with PNES
access traditional healers.
Service gaps
The referral chain from primary care via provincial
healthcare institutes to the final tertiary medical centers
does not work well. As a result, patients may not be referred,
or referrals come directly to tertiary centers without prior
screening, consequently overloading tertiary care centers
with patients. No support groups or education and informa-
tion materials are available.
Proposed solutions
There is a strong need to increase awareness about PNES,
develop the infrastructure for the diagnosis and manage-
ment of patients with PNES, develop proper teaching and
training modules for clinical officers and nonspecialists,
increase the number of health professionals trained in the
management of PNES, and develop a strong referral system.
China
Background
In this large Asian country, population 1.4 billion, GDP
per capita 7,590 USD, over 90% of the population are Han
Chinese, but there are many smaller cultural and ethnic
groups. There are highly variable levels of population den-
sity and urbanization. Physical or sexual abuse is less often
reported by PNES patients than inWestern studies.21
Services
Almost all municipal hospitals have routine EEG and
MRI/CT, and many have video-EEG monitoring units, but
these tests are not available in township hospitals. PNES
may be diagnosed by doctors in different clinical specialties.
PNES are still widely called “pseudoseizures” or “hysteria.”
More comprehensive diagnostic assessments and treatments
involving video-EEG monitoring and cognitive behavioral
therapy (CBT) are only available in larger centers with psy-
chiatry departments.
Diagnosis
About 18% of patients with intractable seizures admitted
for video EEG to the Epilepsy Unit in the West China
Hospital are actually found to have PNES. About one-third
of these were initially misdiagnosed as epilepsy.21,52Misdi-
agnosis rates of two-thirds have been found in patients with
more chronic seizure disorders.53
Treatment
At present, most patients with PNES in China do not have
access to CBT or other forms of psychotherapy. The most
common treatment for PNES in China involves the prescrip-
tion of psychotropic drugs. Some patients do not receive
any treatment at all.21
Service gaps
The referral system in China is not well developed. Many
patients from rural areas and with poor educational or eco-
nomic conditions choose to visit local clinics, in which
PNES are often misdiagnosed and mistreated, whereas bet-
ter placed or informed patients come to tertiary centers
directly, where they may receive a better level of medical
service.
Proposed solutions
There is an urgent need for the development of standard
referral, diagnostic, and treatment processes for PNES in
urban and rural areas of China.
Georgia
Background
This is a predominantly Christian country at the boundary
of Eastern Europe and Asia, with a population 3.7 million
and GDP per capita of 4,435 USD. The mixed cultural
background has produced a historically high level of toler-
ance toward minority religions and ethnic groups. Minority
groups have maintained distinct and separate sociocultural
development, and PNES are observed more commonly in
these groups than in the rest of the population.54
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Services
Specialist medical services were established in 1974
when an epilepsy center was founded at the Tbilisi Sara-
jishvili Institute of Neurology. A standard diagnostic and
treatment protocol has been formulated. From the end of the
1990s, neuropsychiatrists providing therapeutic support for
patients with PNES admitted to the institute have initiated
nonpharmacological treatment.
Diagnosis
All diagnostic techniques are available, but high-resolu-
tion MRI and video-EEG monitoring are only offered in
Tbilisi (the capital), and investigations usually have to be
paid for by patients. Staff at the epilepsy center in Tbilisi
have developed a positive diagnostic approach to PNES
aiming to identify psychopathological processes that
account for PNES. The diagnostic process is generally man-
aged by a neurologist or epileptologist.55,56
Treatment
The provision of nonpharmacological services (i.e., psy-
chotherapy) is a major problem resulting from a shortage of
trained specialists, especially cognitive behavioral thera-
pists. Both health professionals and patients tend to prefer
combined pharmacological and psychotherapeutic interven-
tion (non-CBT), where it is available.
Service gaps
Despite the early introduction of a specialized epilepsy
service in Georgia, currently, because of a fundamental
reorganization of the healthcare system, the treatment of
chronic neurological disorders is not a government health
priority. Private insurance companies cover strictly diagnos-
tic laboratory investigations; however, not all citizens (espe-
cially not all elderly and socially vulnerable persons) have
private medical insurance. The low-income environment
and economically limited healthcare system pose particular
challenges for patients with PNES.
Proposed solutions
Efforts of health policymakers and experts in the field
should be directed to establish more socially oriented poli-
cies for patients with PNES. Intensive training of care provi-
ders, introduction of CBT, and knowledge exchange with
international medical centers could raise diagnostic and
treatment standards while maintaining a culture-specific
management approach.
Japan
Background
This country is a highly industrialized, culturally and eth-
nically uniform East Asian country, with a population of
126 million and GDP per capita of 36,194 USD. PNES
have been studied in Japan since the early 1950s.57
Services
From the early 1900s, psychiatrists familiar with epilepsy
have played a central role in the diagnosis and treatment of
PNES. Although this situation is changing, a substantial
number of psychiatrists still treat PNES patients using a
long-term therapeutic approach.58
Diagnosis
All diagnostic techniques are widely available. High-
resolution MRI and video-EEG monitoring are offered in
every municipal epilepsy center. Investigations are mostly
covered by public health insurance but have to be paid par-
tially by patients (with an upper limit on patient contribu-
tions). In 2009, the Japan Epilepsy Society published a
guideline for the diagnosis and management of PNES.59
Along with video-EEG monitoring, the guideline empha-
sized the significance of longitudinal observation with ther-
apeutic intervention.
Treatment
Along with psychotherapy inclusive of CBT, the PNES
treatment guideline of the Japan Epilepsy Society empha-
sized the significance of environmental adjustment, espe-
cially in patients with ID, aiming to reduce precipitating and
perpetuating factors. Most patients with intractable PNES
are eventually referred to psychiatrists.
Service gaps
Although experts at epilepsy centers effectively differen-
tiate between PNES and epilepsy, the number of psychia-
trists involved in the management of patients with PNES
has gradually decreased.58 As a result, the gap between the
diagnosis of PNES and their treatment is increasing in Japan
(as it may be in other countries where there is a divide
between psychiatry and neurology).
Proposed solutions
It will be crucial to educate not only physicians/neurolo-
gists interested in epilepsy about PNES but also nurses,
psychologists, and occupational therapists. In addition,
young psychiatrists need to be educated about epilepsy and
PNES to prevent further retreat of psychiatrists from epi-
lepsy care.
United Kingdom
Background
In this highly industrialized, culturally and ethnically
diverse Western European country, with a population
65 million and GDP per capita of 46,297 USD, the National
Health Service provides universal health care for all, based
on clinical need and free at the point of delivery. The
National Institute of Clinical Excellence (NICE) recom-
mends diagnostic and treatment pathways on the basis of
evidence.
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Services
PNES are usually diagnosed by general neurologists. All
neurologists have access to routine EEG, most, to video
EEG. Access to epilepsy/PNES experts is limited. Treat-
ment is provided by clinical psychology/psychotherapy ser-
vices, typically in community or mental health settings.
Although some psychotherapy provision exists almost
everywhere, access to psychotherapy with expertise in the
treatment of PNES is very limited. Most psychiatrists have a
limited understanding of PNES (or epilepsy).
Diagnosis
Despite widespread access to video EEG, 30% of PNES
diagnoses are made on clinical grounds.6 There are no
national guidelines for the diagnosis of PNES. The diagno-
sis is communicated by neurologists. Many use leaflets or
websites to support the explanation. Most patients are
referred to psychologists or psychiatrists for further
exploration.
Treatment
There are no national treatment guidelines for PNES in
the United Kingdom. Most patients are referred for psycho-
logical treatment but receive only a small number of ses-
sions from therapists unfamiliar with PNES. Exceptions
exist in centers of excellence. A large multicenter RCT of a
CBT approach for PNES is under way.60
Service gaps
Despite improving knowledge about PNES, most
patients are initially misdiagnosed as having epilepsy,
and the mean delay between PNES manifestation and
diagnosis is around 5 years. Psychiatrists, psychologists,
and psychotherapists not working in epilepsy centers have
a very limited understanding of PNES, and access to
longer psychotherapy programs (more than six sessions)
is limited.
Proposed solutions
The completion of the multicenter CBT RCT may gener-
ate the evidence required to persuade the National Institute
for Clinical Excellence (NICE) to issue guidance for the
diagnosis and treatment of PNES.60 The integration of train-
ing modules about PNES in neurological and psychiatric
specialist education may improve understanding of the dis-
order in the future.
United States
Background
This is a highly industrialized country with an ethnically,
culturally, and religiously diverse native-born and immi-
grant population of 322 million, with GDP per capita of
55,805 USD. Urban and rural settings have a wide array of
healthcare services. The Affordable Care Act of 2010
expanded provisions covered by public and private insur-
ance to those formerly uninsured.
Services
Routine EEG, ambulatory EEG, and video EEG are avail-
able in tertiary care epilepsy referral centers across the
country. Treatment is provided at a handful of epilepsy cen-
ters where outpatient individual and group therapy is
offered for adults with PNES. The majority of psychiatrists
and psychologists in the U.S.A., however, do not follow up
or treat patients with PNES or other conversion disorders.
Diagnosis
Video EEG is available at all Level 3 and Level 4 Epi-
lepsy Centers and at Veteran Administration (VA) Epilepsy
Centers of Excellence (ECoE). There are no national guide-
lines for the diagnosis of PNES; however, video EEG is
accepted as the diagnostic gold standard. The diagnosis is
communicated by neurologists, with some epilepsy unit
teams incorporating mental health providers. Patients are
referred to mental health providers, but not all engage.5
Treatment
There are no national treatment guidelines for patients
with PNES. A pilot multicenter RCT using a manualized
cognitive behavioral–informed psychotherapy revealed
decreased seizures, comorbid psychiatric symptoms, and
improved quality of life in the therapy arms.31 The seizure
therapy treatment workbook is being used by patients and
providers in the VA ECoEs and in some Level 4 Epilepsy
Centers.
Service gaps
Despite diagnosing many patients with PNES, most civil-
ian Level 4 Epilepsy Centers still do not provide treatment
for patients with PNES. A growing number of VA ECoEs
provide treatment for veterans with PNES using trained pro-
viders on site and via computer video telehealth.61,62
Proposed solutions
As more civilian and VA hospitals develop clinics that
are successfully treating patients with PNES and with epi-
lepsy using the Seizure Workbook,63,64 more sites will be
trained to deliver evidence-based interventions.
Addressing Gaps in Diagnostic
and Treatment Services for
PNES
The reduction in quality of life experienced by people
with PNES is well documented and is a major global public
health issue.65 Our understanding of the management of
this condition has improved significantly over the past dec-
ade. Unfortunately, clinical studies showing what is
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possible in terms of treatment and strong evidence of per-
sonal and public health need are unlikely in themselves to
alter care. We suggest that six key themes can be
addressed. These combine to offer a route map nationally
and globally to build the care of people with PNES over
the next decade.
Access to diagnostic process
We have established criteria for diagnosis, with minimum
standards to allow their use in global healthcare settings.
There is a need to develop country-specific resources, at
least to provide minimum diagnostic services to ensure that
all people can have a diagnosis made and communicated to
an appropriate standard.3
Development of treatment pathways
The development of evidence-based treatments for PNES
has advanced significantly in the last 10 years.4 However,
interventions have not as yet been universally adopted,
specifically by psychological and psychiatric service provi-
ders. Treatment pathways need to be developed either
within epilepsy services or generic psychiatric services.
Such pathways must be adapted to local service structures
but must be inclusive to ensure people with PNES are not
excluded because they fall outside the range of treatments
routinely addressed by psychological service providers
(e.g., for mood or anxiety disorders).
Providing services for patients with chronic PNES
disorders
Although some patients with PNES remit simply after a
decent explanation of the diagnosis with or without ensuing
short-term CBT programs,10,16,31 a substantial number of
patients need longer-term psychotherapeutic or mental
health interventions either because of continuing PNES or
background psychosocial problems that remain unchanged
even after the cessation of PNES.29,66 Although most recent
research efforts on PNES have been directed at the commu-
nication of the diagnosis or short-term treatments, the latter
group of patients have been largely neglected, even in well-
resourcedWestern countries.29,65
Closing the gap between neurology and psychiatry
The ongoing and increasing process of subspecialization
across all fields of medicine has contributed to a widening
gap between neurology and psychiatry in many countries
around the world. For many patients with PNES, this gap
means that different medical specialties are responsible for
the diagnosis and treatment of their disorder. This disconti-
nuity of the diagnosis-treatment pathway causes many
patients not to access treatment after a diagnosis of PNES
has been made. Better education of neurologists about the
management of the mental health problems they commonly
encounter (including PNES) and of psychiatrists about sei-
zures (epileptic and nonepileptic) and closer working
relationships between health professionals could help to
close this gap.
The individualization of care—a blueprint for
conversion/dissociative disorders
The dominant theme of health care is toward a more indi-
vidualized approach. The approach is underpinned by a
credo that all conditions will be understandable on an indi-
vidual genetic level. In the field of PNES this goal currently
seems beyond reach, but recent progress in the neurobiolog-
ical and psychological underpinnings of PNES will hope-
fully allow us to better tailor treatments to individual
patients in this heterogeneous patient population.14,67 Our
deepening understanding of this condition hopefully also
means that agencies that fund research and service develop-
ments will recognize the importance of this disabling disor-
der and that stigma will be reduced.68
Ensuring that patients are well informed and
empowered
This is possibly the largest challenge, but one that must
be achieved for change to occur. In many branches of medi-
cine patients are being empowered as their own advocates
to navigate their health journey. The same process needs to
be developed for people with PNES. PNES patient groups
in the U.S.A. and the United Kingdom demonstrate that it is
possible to develop patient advocates who can support pro-
fessionals in the drive to improve access to diagnostic and
treatment services.
Conclusion
The Japan PNES conference built on prior workshops and
identified gaps in care for patients with PNES, not only in
poor countries but around the world. Apart from highlight-
ing that, just like epilepsy, PNES is a global problem, this
article demonstrates how patients with this disorder and pro-
fessionals keen to help them face different problems around
the world. This article hints at some of the possible solu-
tions. Although many of the recent scientific findings about
the etiology and treatment of PNES summarized here are
likely to be universally true, optimal solutions or improve-
ments will have to be specific to individual countries,
reflecting the different cultural traditions of each.
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